215 related articles for article (PubMed ID: 37399185)
21. Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution.
Hemmelgarn BR; Manns BJ; Soroka SD; Levin A; MacRae J; Tennankore K; Wilson JS; Weaver RG; Ravani P; Quinn RR; Tonelli M; Kiaii M; Mossop P; Scott-Douglas N
Clin J Am Soc Nephrol; 2018 Mar; 13(3):429-435. PubMed ID: 29335321
[TBL] [Abstract][Full Text] [Related]
22. Trisodium citrate 4%--an alternative to heparin capping of haemodialysis catheters.
Lok CE; Appleton D; Bhola C; Khoo B; Richardson RM
Nephrol Dial Transplant; 2007 Feb; 22(2):477-83. PubMed ID: 17018541
[TBL] [Abstract][Full Text] [Related]
23. Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long-term central venous catheters in infants and children.
Bradford NK; Edwards RM; Chan RJ
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010996. PubMed ID: 32352563
[TBL] [Abstract][Full Text] [Related]
24. Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial.
Gilbert RE; Mok Q; Dwan K; Harron K; Moitt T; Millar M; Ramnarayan P; Tibby SM; Hughes D; Gamble C;
Lancet; 2016 Apr; 387(10029):1732-42. PubMed ID: 26946925
[TBL] [Abstract][Full Text] [Related]
25. Safety and Efficacy of Acute Central Venous Catheters for Hemodialysis with Sodium Bicarbonate versus an Antibiotic Catheter Locking Solution.
Ali SS; Swami R; Shakir A; Mehta K
Saudi J Kidney Dis Transpl; 2023 Nov; 34(6):507-513. PubMed ID: 38725200
[TBL] [Abstract][Full Text] [Related]
26. A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients.
Gudiol C; Arnan M; Aguilar-Guisado M; Royo-Cebrecos C; Sánchez-Ortega I; Montero I; Martín-Gandul C; Laporte-Amargós J; Albasanz-Puig A; Nicolae S; Perayre M; Berbel D; Tebe C; Riera J; Sureda A; Cisneros JM; Carratalà J
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712211
[TBL] [Abstract][Full Text] [Related]
27. Systemic anticoagulation related to heparin locking of non-tunnelled venous dialysis catheters in intensive care patients.
Bong YC; Walsham J
Anaesth Intensive Care; 2016 Jul; 44(4):474-6. PubMed ID: 27456177
[TBL] [Abstract][Full Text] [Related]
28. Concentrated sodium chloride catheter lock solution--a new effective alternative method for hemodialysis patients with high bleeding risk.
Chen FK; Li JJ; Song Y; Zhang YY; Chen P; Zhao CZ; Gong HY; Yao DF
Ren Fail; 2014 Feb; 36(1):17-22. PubMed ID: 23992231
[TBL] [Abstract][Full Text] [Related]
29. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
Trials; 2018 May; 19(1):264. PubMed ID: 29720244
[TBL] [Abstract][Full Text] [Related]
30. Evidence-based criteria for the choice and the clinical use of the most appropriate lock solutions for central venous catheters (excluding dialysis catheters): a GAVeCeLT consensus.
Pittiruti M; Bertoglio S; Scoppettuolo G; Biffi R; Lamperti M; Dal Molin A; Panocchia N; Petrosillo N; Venditti M; Rigo C; DeLutio E
J Vasc Access; 2016 Nov; 17(6):453-464. PubMed ID: 27516141
[TBL] [Abstract][Full Text] [Related]
31. The effect of different flushing and locking techniques on catheter occlusion rates in central venous catheters: protocol for a multicentre, randomized controlled, parallel-group, open-label, superiority clinical trial.
Li R; Zhou M; Sun L; Sha L; Xu B; Li T; Tao T; Yuan L
Trials; 2024 Jun; 25(1):380. PubMed ID: 38867301
[TBL] [Abstract][Full Text] [Related]
32. Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients.
Moore CL; Besarab A; Ajluni M; Soi V; Peterson EL; Johnson LE; Zervos MJ; Adams E; Yee J
Clin J Am Soc Nephrol; 2014 Jul; 9(7):1232-9. PubMed ID: 24970874
[TBL] [Abstract][Full Text] [Related]
33. Trisodium citrate: an alternative to unfractionated heparin for hemodialysis catheter dwells.
Pierce DA; Rocco MV
Pharmacotherapy; 2010 Nov; 30(11):1150-8. PubMed ID: 20973688
[TBL] [Abstract][Full Text] [Related]
34. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D
Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
[TBL] [Abstract][Full Text] [Related]
35. Concentrated sodium citrate catheter lock: "The best laid schemes o' mice an' men…".
Ash SR
Artif Organs; 2022 Aug; 46(8):1701-1704. PubMed ID: 35733080
[TBL] [Abstract][Full Text] [Related]
36. Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial.
Tribler S; Brandt CF; Petersen AH; Petersen JH; Fuglsang KA; Staun M; Broebech P; Moser CE; Jeppesen PB
Am J Clin Nutr; 2017 Sep; 106(3):839-848. PubMed ID: 28793993
[No Abstract] [Full Text] [Related]
37. [Comparison of citrate 4% and heparin as tunneled-catheters-locking solution in chronic hemodialysis].
Chazot G; Mehdi M; Lorriaux C; Deleaval P; Mayor B; Jean G; Chazot C; Lechevallier S; Moncel O; Vo-Van C; Hurot JM
Nephrol Ther; 2018 Feb; 14(1):42-46. PubMed ID: 29191576
[TBL] [Abstract][Full Text] [Related]
38. Reduction of biofilm formation with trisodium citrate in haemodialysis catheters: a randomized controlled trial.
Bosma JW; Siegert CE; Peerbooms PG; Weijmer MC
Nephrol Dial Transplant; 2010 Apr; 25(4):1213-7. PubMed ID: 19948873
[TBL] [Abstract][Full Text] [Related]
39. Effect of taurolidine citrate and unfractionated heparin on inflammatory state and dialysis adequacy in hemodialysis patients.
Ezzat H; Elsharkawy M; Rezk K; Mohsen R; Mansour A; Emara A
J Vasc Access; 2023 Jan; 24(1):45-51. PubMed ID: 34112001
[TBL] [Abstract][Full Text] [Related]
40. Long-term effect of an ethanol/sodium citrate locking solution on the mechanical properties of hemodialysis catheters.
Vercaigne LM; Takla TA; Raghavan J
J Vasc Access; 2010; 11(1):12-6. PubMed ID: 20119926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
